Immunovant, Inc. (IMVT)
IMVT price $28.38 -0.21 -0.73%
- Ticker
- IMVT
- Price
- $28.38
- Change
- -0.21 -0.73%
- Market cap
- $5.86B
- P/E
- -10.06
- Forward P/E
- 200.66
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 62
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in…